# Evaluation of Immune Responses and Outcomes in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy

> **NCT06379256** · — · RECRUITING · sponsor: **Chang Gung Memorial Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **RADIATION:** Photon or proton radiotherapy

## Key facts

- **NCT ID:** NCT06379256
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-23
- **Primary completion:** 2029-03-17
- **Final completion:** 2032-03-17
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06379256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06379256, "Evaluation of Immune Responses and Outcomes in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06379256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*